Supplementary Figure 5 from Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 5. MGMT promoter methylation in orthotopically implanted LN- 229, LN-229Res, and D54Res glioblastomas.
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361919277